• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受辐照小鼠体内的终末期前宿主树突状细胞引发CD8 + T细胞介导的急性移植物抗宿主病。

Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease.

作者信息

Zhang Yi, Louboutin Jean-Pierre, Zhu Jiang, Rivera Adam J, Emerson Stephen G

机构信息

Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

出版信息

J Clin Invest. 2002 May;109(10):1335-44. doi: 10.1172/JCI14989.

DOI:10.1172/JCI14989
PMID:12021249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC150980/
Abstract

To understand the relationship between host antigen-presenting cells (APCs) and donor T cells in initiating graft-versus-host disease (GVHD), we followed the fate of host dendritic cells (DCs) in irradiated C57BL/6 (B6) recipient mice and the interaction of these cells with minor histocompatibility antigen- (miHA-) mismatched CD8+ T cells from C3H.SW donors. Host CD11c+ DCs were rapidly activated and aggregated in the T cell areas of the spleen within 6 hours of lethal irradiation. By 5 days after irradiation, <1% of host DCs were detectable, but the activated donor CD8+ T cells had already undergone as many as seven divisions. Thus, proliferation of donor CD8+ T cells preceded the disappearance of host DCs. When C3H.SW donor CD8+ T cells were primed in vivo in irradiated B6 mice or ex vivo by host CD11c+ DCs for 24-36 hours, they were able to proliferate and differentiate into IFN-gamma-producing cells in beta(2)-microglobulin-deficient (beta(2)m(-/-)) B6 recipients and to mediate acute GVHD in beta(2)m(-/-) --> B6 chimeric mice. These results indicate that, although host DCs disappear rapidly after allogeneic bone marrow transplantation, they prime donor T cells before their disappearance and play a critical role in triggering donor CD8+ T cell-mediated GVHD.

摘要

为了解宿主抗原呈递细胞(APC)与供体T细胞在引发移植物抗宿主病(GVHD)中的关系,我们追踪了受辐照的C57BL/6(B6)受体小鼠中宿主树突状细胞(DC)的命运,以及这些细胞与来自C3H.SW供体的次要组织相容性抗原(miHA)不匹配的CD8 + T细胞的相互作用。在致死性辐照后6小时内,宿主CD11c + DC迅速被激活并聚集在脾脏的T细胞区域。辐照后5天,可检测到的宿主DC不到1%,但活化的供体CD8 + T细胞已经经历了多达7次分裂。因此,供体CD8 + T细胞的增殖先于宿主DC的消失。当C3H.SW供体CD8 + T细胞在辐照的B6小鼠体内或在体外由宿主CD11c + DC致敏24 - 36小时后,它们能够在β2微球蛋白缺陷(β2m(-/-))的B6受体中增殖并分化为产生IFN-γ的细胞,并在β2m(-/-)→B6嵌合小鼠中介导急性GVHD。这些结果表明虽然在异基因骨髓移植后宿主DC迅速消失,但它们在消失前激活供体T细胞,并在触发供体CD8 + T细胞介导的GVHD中起关键作用。

相似文献

1
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease.受辐照小鼠体内的终末期前宿主树突状细胞引发CD8 + T细胞介导的急性移植物抗宿主病。
J Clin Invest. 2002 May;109(10):1335-44. doi: 10.1172/JCI14989.
2
Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.源自宿主CD8记忆T细胞的效应细胞介导对次要组织相容性抗原错配的同种异体骨髓移植的快速抗性,且无需穿孔素、Fas配体参与,同时抑制3种肿瘤坏死因子家族效应途径。
Biol Blood Marrow Transplant. 2005 Aug;11(8):576-86. doi: 10.1016/j.bbmt.2005.05.006.
3
Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.体外激活的γδT细胞的移植物促进剂量不会引发致死性小鼠移植物抗宿主病。
Biol Blood Marrow Transplant. 1999;5(4):222-30. doi: 10.1053/bbmt.1999.v5.pm10465102.
4
Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.参与移植物抗宿主病的次要组织相容性抗原的CD8 + T细胞反应的库分析。
J Immunol. 1998 Jul 1;161(1):41-8.
5
Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.特定供体Vβ相关的CD4 T细胞反应与针对多种次要组织相容性抗原的严重急性移植物抗宿主病相关。
Biol Blood Marrow Transplant. 2004 Feb;10(2):91-105. doi: 10.1016/j.bbmt.2003.10.002.
6
T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.参与针对免疫显性次要组织相容性抗原的致死性移植物抗宿主病的T细胞亚群。
Transplantation. 1994 Apr 15;57(7):1095-102.
7
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.供体抗原呈递细胞在异基因骨髓移植后调节T细胞扩增和抗肿瘤活性。
Biol Blood Marrow Transplant. 2004 Aug;10(8):540-51. doi: 10.1016/j.bbmt.2004.05.007.
8
A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.一种CD8 DE环肽类似物在多微小组织相容性抗原不匹配的骨髓移植模型中可预防移植物抗宿主病。
Biol Blood Marrow Transplant. 2004 Oct;10(10):669-80. doi: 10.1016/j.bbmt.2004.06.005.
9
B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.B7.2基因敲除的成熟树突状细胞在子宫内同种异体骨髓移植后,可在胎鼠中产生辅助性T细胞2和调节性T供体细胞。
Biol Blood Marrow Transplant. 2005 Sep;11(9):657-71. doi: 10.1016/j.bbmt.2005.05.012.
10
An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.供体细胞上缺乏CCR5会导致急性移植物抗宿主病加速。
Exp Hematol. 2004 Mar;32(3):318-24. doi: 10.1016/j.exphem.2003.12.003.

引用本文的文献

1
Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice.人源化小鼠实验性移植物抗宿主病的病理生理学及临床前相关性
Biomark Res. 2024 Nov 14;12(1):139. doi: 10.1186/s40364-024-00684-9.
2
Defining a TCF1-expressing progenitor allogeneic CD8 T cell subset in acute graft-versus-host disease.定义急性移植物抗宿主病中 TCF1 表达祖细胞同种异体 CD8 T 细胞亚群。
Nat Commun. 2023 Sep 22;14(1):5869. doi: 10.1038/s41467-023-41357-9.
3
Infection and inflammation stimulate expansion of a CD74 Paneth cell subset to regulate disease progression.感染和炎症会刺激 CD74 潘氏细胞亚群的扩增,从而调节疾病的进展。
EMBO J. 2023 Nov 2;42(21):e113975. doi: 10.15252/embj.2023113975. Epub 2023 Sep 18.
4
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD).移植物抗宿主病(GvHD)的免疫代谢治疗靶点
Metabolites. 2021 Oct 27;11(11):736. doi: 10.3390/metabo11110736.
5
Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation.靶向 CD27-CD70 通路改善免疫检查点治疗和异基因造血细胞移植的疗效。
Front Immunol. 2021 Sep 22;12:715909. doi: 10.3389/fimmu.2021.715909. eCollection 2021.
6
Murine Models Provide New Insights Into Pathogenesis of Chronic Graft--Host Disease in Humans.鼠类模型为慢性移植物抗宿主病的发病机制提供了新的见解。
Front Immunol. 2021 Sep 3;12:700857. doi: 10.3389/fimmu.2021.700857. eCollection 2021.
7
Low-dose total body irradiation facilitates antitumoral Th1 immune responses.低剂量全身辐射促进抗肿瘤 Th1 免疫应答。
Theranostics. 2021 Jun 16;11(16):7700-7714. doi: 10.7150/thno.61459. eCollection 2021.
8
The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations.干扰素对移植物抗宿主病中同种异体 T 细胞反应的影响:多方面的生物学和表观遗传学调控。
Front Immunol. 2021 Jul 8;12:717540. doi: 10.3389/fimmu.2021.717540. eCollection 2021.
9
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells.人类不变自然杀伤 T 细胞通过优先诱导常规树突状细胞凋亡促进耐受。
Haematologica. 2022 Feb 1;107(2):427-436. doi: 10.3324/haematol.2020.267583.
10
Current Concepts and Advances in Graft-Versus-Host Disease Immunology.当前移植物抗宿主病免疫学的概念和进展。
Annu Rev Immunol. 2021 Apr 26;39:19-49. doi: 10.1146/annurev-immunol-102119-073227. Epub 2021 Jan 11.

本文引用的文献

1
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.T细胞清除作为异基因造血干细胞移植预防移植物抗宿主病的历史与未来
Blood. 2001 Dec 1;98(12):3192-204. doi: 10.1182/blood.v98.12.3192.
2
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.小鼠对全身性腺病毒载体的急性细胞因子反应由树突状细胞和巨噬细胞介导。
Mol Ther. 2001 May;3(5 Pt 1):697-707. doi: 10.1006/mthe.2001.0329.
3
Dendritic cells in transplantation--friend or foe?移植中的树突状细胞——是友还是敌?
Immunity. 2001 Apr;14(4):357-68. doi: 10.1016/s1074-7613(01)00116-9.
4
Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.初始细胞毒性T淋巴细胞(CTL)需要一段短暂的抗原刺激来进行克隆扩增和分化。
Nat Immunol. 2001 May;2(5):423-9. doi: 10.1038/87730.
5
Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells.记忆性CD8 + T细胞分化:初始抗原接触触发幼稚细胞中的一个发育程序。
Nat Immunol. 2001 May;2(5):415-22. doi: 10.1038/87720.
6
Acute graft-vs-host disease: pathobiology and management.急性移植物抗宿主病:病理生物学与管理
Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9.
7
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.CD8(+)而非CD8(-)树突状细胞在体内交叉启动细胞毒性T细胞。
J Exp Med. 2000 Dec 18;192(12):1685-96. doi: 10.1084/jem.192.12.1685.
8
Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates.当用凋亡细胞和坏死细胞脉冲处理时,树突状细胞能有效地交叉激活HLA I类限制性细胞毒性T淋巴细胞,但用可溶性细胞来源的裂解物处理则不能。
Int Immunol. 2000 Dec;12(12):1741-7. doi: 10.1093/intimm/12.12.1741.
9
Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.宿主T细胞可抵抗供体白细胞输注介导的移植物抗宿主病。
J Immunol. 2000 Nov 1;165(9):4901-9. doi: 10.4049/jimmunol.165.9.4901.
10
Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.急性移植物抗宿主病的发病机制:细胞因子与细胞效应器
J Hematother Stem Cell Res. 2000 Jun;9(3):299-306. doi: 10.1089/15258160050079407.